证券记录 · 已归档季度
ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
19被追踪持有人
0Δ持有人
50.59M持有股份
$8.32B报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -7.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 944.24K | $65.94M | n/a | −2 |
| Q2 2026 | 173 | +5 | 278.21M | $20.02B | +9 | −5 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | n/a | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | n/a |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | n/a | n/a |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | n/a |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | n/a | 38.28M | $6.63B | n/a | n/a |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 19.80M | -0.2% | $3.26B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 10.99M | +3.5% | $1.80B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 6.07M | -12.8% | $998.66M | 0.2% | ▼ Trim | 4 | SEC ↗ ×4 |
| 4 | Norges Bank ✦ (被动) | 5.09M | +0.7% | $838.59M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Capital World Investors ✦ | 3.97M | -39.5% | $653.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.46M | -20.2% | $241.18M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Arrowstreet Capital ✦ | 648.41K | +142.2% | $106.76M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 616.38K | +109.9% | $100.57M | 0.1% | ▲ Add | 4 | SEC ↗ ×6 |
| 9 | Millennium Management ✦ | 544.43K | +28.0% | $89.64M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | Marshall Wace ✦ | 363.59K | -53.9% | $59.87M | 0.1% | ▼ Trim | 4 | SEC ↗ ×3 |
| 11 | Adage Capital Partners ✦ | 344.34K | +154.6% | $56.70M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 331.27K | +14.8% | $54.54M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 13 | Bridgewater Associates ✦ | 144.03K | +46.4% | $23.72M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 102.92K | -25.6% | $16.95M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 83.19K | -92.4% | $13.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 17.93K | +124.9% | $2.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | GAMCO Investors ✦ | 11.79K | -11.9% | $1.94M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 2.86K | +0.4% | $471,228 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Dodge & Cox ✦ | 1.70K | 0.0% | $279,905 | 0.0% | Held | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,596 持有人, 404.54M 股份, $46.32B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Jul 30
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据